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Case Presentation

61 year-old male with a past medical history of coronary artery
disease complicated by myocardial infarction in 1984, type 2
diabetes mellitus, hyperlipidemia, hypertension, and right total
knee replacement in 2006 presents to the outpatient allergist’s office
for evaluation. The patient reports that he never fully recovered
after the knee surgery and never regained function. The right knee
remained swollen and painful with limited range of motion and
weight bearing as a result. He denies any rash, redness, or itching in
the area. He also denies any history of reactions to metals in the past.
The orthopedic surgeon referred the patient to an allergist to assess
for an allergic reaction to various components of the orthopedic
hardware prior to the right knee revision surgery.
The patient has no known drug allergies. His medications include
insulin 70/30 at breakfast and dinner, diltiazem CD 360 mg daily,
simvastatin 20 mg daily, lisinopril 10 mg daily, metoprolol 12.5 mg
twice daily, nitroglycerine patch for 12 hours daily, alprazolam 5mg
three times a day for anxiety, and naproxen and percocet as needed
for pain. The patient is a lifetime non-smoker and stopped drinking
alcohol over 20 years ago. Family history is significant for coronary
artery disease and prostate cancer. There is no family history of
asthma or allergy.
At the initial visit, the patient was afebrile with stable vital signs.
The physical exam was unremarkable except for right knee
swelling, decreased range of motion, a well-healed midline scar,
and 1+ edema of the right lower extremity up to the knee. The
knee was non-tender and no warmth or erythema was noted.
To evaluate for delayed hypersensitivity reaction, a panel of
allergens using the Thin-layer Rapid Use Epicutaneous (TRUE)
patch test were placed on the patient’s skin. A vitallium metal
disk, a known component of the prosthesis, was also placed on
the patient’s skin. At 48 hours, the patch test was clearly positive
for black rubber and possibly positive for potassium dichromate
and Balsam of Peru. Since the patch did not stay entirely adherent
to the skin, the adhesive was reinforced and the patient was
instructed to return the next day for a 72-hour reading. At the
second reading, the test remained strongly positive to black
rubber. In addition, potassium dichromate showed strongly
positive reaction, and cobalt dichloride showed weakly positive
reaction. Upon re-examination, the reaction to Balsam of Peru
appeared more likely to be irritation and not a true reaction.
Given that the patient’s knee prosthesis was composed of 30%
chromium, suspicion for metal allergy to the prosthesis was high.
The finding was communicated to the orthopedic surgeon for
consideration in further management of the patient’s condition.

Discussion

Metal hypersensitivity is common in the general population and
often manifests as contact dermatitis to various everyday items
including jewelry, watches, and belt buckles. The exposure may
also occur in the form of metal ions dissolved in food and water.
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If ingested, metal ions can cause similar dermatological reactions
or more systemic reactions such as asthma-like symptoms.1
The most common metal hypersensitivity is to nickel, followed
by cobalt and chromium.2 Nickel and cobalt show significant
cross-reactivity.
Metal allergy involves the type IV hypersensitivity response,
also known as the cell-mediated delayed-type hypersensitivity
(DTH). In DTH reaction, antigens are taken up and expressed
on antigen presenting cells (APCs) which activate sensitized Th1
lymphocytes, a subpopulation of T-cells. The T-cells then release
various cytokines, which in turn recruit and activate macrophages,
monocytes, neutrophils, and other inflammatory cells.3 Activated
macrophages can trigger the activation of more T-cells, perpetuating
the inflammatory response and leading to extensive tissue damage.3
Metals or metal ions on their own are not known to activate the
immune system. Rather, it is the metal-protein complexes, formed
by the degraded metal products binding to the native proteins, that
can function as antigens and elicit an immune response.3 Specific
APCs and T-cell receptors implicated in the DTH responses to
metal are yet unidentified, and the current management for metal
hypersensitivity is mainly based on exposure avoidance.
Metal prostheses, as with all metal exposed to biological
environment, are known to corrode over time and release wear
debris into the joint space. Nickel and cobalt ions seem to clear
rapidly from the synovial space and are eliminated in the urine, but
chromium appears to be stored in the tissue and eliminated more
slowly.5 Concern for metal hypersensitivity to joint prosthesis
was first raised in several case reports from the early 1970s, which
noted that some patients with metal-on-metal joint replacement
developed reactions that may be allergic in nature.1 Since then,
implant-related metal hypersensitivity has been documented
in numerous case reports and cohort studies. Still, as a clinical
entity, it is only loosely characterized and poorly understood.
Commonly reported findings include eczematous rash, either
generalized or on the skin overlying the orthopedic implants, along
with discomfort, pain, erythema, and swelling over the affected
joint.2 Some patients also report malaise, fatigue, and general
weakness.2 Most concerning of all, DTH to metal prostheses has
been cited as at least partially responsible for “aseptic loosening”
of the prosthetic joint, in which chronic imflammatory-mediated
osteolysis around the implant leads to loss of fixation and eventual
implant removal.4 In suspected cases of implant-associated DTH
reactions, the synovial fluid tends to be culture negative and have
only few leukocytes. Histologically, inflammation and oligoclonal
T-cell infiltrates are present in the peri-implant tissue, indicating
an immune-mediated process, and cytokines typical of DTH,
such as IL-6 and INF-γ, are expressed in high concentrations.5
The conventional method of diagnosing metal hypersensitivity is
by patch testing, in which a panel of antigens is exposed directly
onto the skin for 48 to 96 hours, and the resulting dermatological
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reactions are graded.3 It is a less-than-ideal method since the skin
is a natural barrier that protects the immune system from antigen
exposure. In the case of implant-associated metal hypersensitivity,
patch testing is even more unreliable since the synovial cavity has
a different cellular and biochemical composition than the skin.2
Furthermore, there is at least the theoretical concern that patch
testing could induce a hypersensitivity reaction in previously
insensitive patient.3 Several in vitro studies for testing DTH are
available, although their value specifically in implant-associated
metal hypersensitivity has not been studied extensively.
Lymphocyte transformation testing (LTT) measures the
proliferative response of lymphocytes to a designated challenge
antigen.3 Leukocyte migration inhibition testing (LIF or MIF)
measures the migration of lymphocytes on a culture medium
in the presence of a sensitizing antigen which tends to inhibit
migration.3 Unfortunately, both LTT and LIF are labor-intensive
and lack the sensitivity and specificity to be reliable in the clinical
setting. At this time, diagnosis of implant-associated metal
hypersensitivity is largely based on clinical presentation and
exclusion of other etiologies.
Can patients be screened for metal allergy prior to undergoing
joint replacement surgery? Some studies have suggested that
patients with documented metal allergy have more symptoms
of implant-associated DTH and that positive patch test to metal
is more common in patients with failed joint prostheses than
in those with well-functioning prostheses.1 However, studies
that looked at pre- and postoperative sensitization to metal
showed that a significant number of patients develop metal
sensitivity postoperatively.1,3,4 Furthermore, only a fraction of
those with positive patch test, both pre- and postoperatively,
developed clinical manifestations of DTH to metal implants.1,3,4
In fact, many of those with positive patch tests had no history of
reaction to metal. Studies that used in vitro tests independently
or in combination with the patch test also failed to produce any
consistent findings. At this point, there is no reliable method to
assess for implant-associated metal allergy preoperatively.

Since DTH does not involve the histamine-release pathway, the
common allergy medications are ineffective in treating metal
prosthesis allergy. Low-dose corticosteroids have been used as
a temporary solution, but their numerous adverse side effects
deem them inappropriate for long term treatment.2 As with
the cutaneous form of metal hypersensitivity, the definitive
treatment for implant-associated metal hypersensitivity is
elimination and avoidance, or, in other words, surgical removal
of the metal prosthesis. Although removal of the offending
prosthesis generally leads to complete and prompt healing, the
revision surgery is obviously a serious undertaking. Biologically
more inert materials are under investigation as alternatives to the
currently available metal prostheses. Also, research is underway
to determine genetic polymorphisms for factors involved in
DTH and to develop targeted immunosuppressive agents.4
Implant-associated metal hypersensitivity is an extremely
rare condition. However, in those few who are affected the
consequences are grave. The condition is probably underrecognized and under-reported due to the difficulty of diagnosis.
More research, including longitudinal prospective studies, are
needed to better understand this immunological, rheumatological,
and surgical enigma.
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